Experimental retinal vein occlusion: Effect of acetazolamide and carbogen (95% O2/5% CO2) on preretinal PO2

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 10, 2004, Pages 3669-3677

  Pournaras, Jean Antoine C ^a   Petropoulos, Ioannis K ^a   Munoz, Jean Luc ^a   Pournaras, Constantin J ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ATROPINE; AZAPERONE; CARBOGEN; MIDAZOLAM MALEATE; OXYGEN; PANCURONIUM BROMIDE; THIOPENTAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARGON LASER; ARTICLE; BREATHING; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; HYPEROXIA; MICROELECTRODE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; SWINE; TISSUE OXYGENATION; TREATMENT OUTCOME; VITREOUS BODY;

ACETAZOLAMIDE; ANIMALS; CARBON DIOXIDE; CARBONIC ANHYDRASE INHIBITORS; HYPEROXIA; INJECTIONS, INTRAVENOUS; ION-SELECTIVE ELECTRODES; ISCHEMIA; MICROELECTRODES; OXYGEN; OXYGEN CONSUMPTION; PARTIAL PRESSURE; RESPIRATION; RETINA; RETINAL VEIN OCCLUSION; SWINE; SWINE, MINIATURE;

EID: 4644298763     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0086     Document Type: Article

References (59)

1. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117:429-441.
2. Kohner EM, Dollery CT, Shakib M, et al. Experimental retinal branch vein occlusion. Am J Ophthalmol. 1970;69:778-825.
3. Danis RP, Wallow IH. Microvascular changes in experimental branch retinal vein occlusion. Ophthalmology. 1987;94:1213-1221.
4. Rosen DA, Marshall J, Kohner EM, Hamilton AM, Dollery CT. Experimental retinal branch vein occlusion in rhesus monkeys. II. Retinal blood flow studies. Br J Ophthalmol. 1979;63:388-392.
5. Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology. 1983;90:488-506.
6. Gutman FA. Macular edema in branch retinal vein occlusion: prognosis and management. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:488-495.
7. Michels RG, Gass JDM. The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:166-177.
8. Van Heuven WA, Hayreh MS, Hayreh SS. Experimental central retinal vascular occlusion. Blood-retinal barrier alterations and retinal lesions. Trans Ophthalmol Soc UK. 1977;97:588-618.
9. Pournaras CJ, Tsacopoulos M, Leuenberger PM, Gilodi N. Occlusion veineuse expérimentale: physiopathologie des altérations de la barrière hématorétinienne. Ophtalmologie. 1987;1:497-499.
10. Wallow IH, Danis RP, Bindley C, Neider M. Cystoid macular degeneration in experimental branch retinal vein occlusion. Ophthalmology. 1988;95:1371-1379.
11. Donati G, Pournaras CJ, Pizzolato GP, Tsacopoulos M. Decreased nitric oxide production accounts for secondary arteriolar constriction after retinal branch vein occlusion. Invest Ophthalmol Vis Sci. 1997;38:1450-1457.
12. Donati G, Pournaras CJ, Munoz JL, Poitry S, Poitry-Yamate CL, Tsacopoulos M. Nitric oxide controls arteriolar tone in the retina of the miniature pig. Invest Ophthalmol Vis Sci. 1995;36:2228-2237.
13. 2 in normal and ischemic retinas of anesthetized miniature pigs in normoxia and hyperoxia. Graefes Arch Clin Exp Ophthalmol. 1990;228:138-142.
14. Hansen LL, Wiek J, Wiederholt M. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol. 1989;73:895-899.
15. Chen HC, Wiek J, Gupta A, Luckie A, Kohner EM. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol. 1998;82:162-167.
16. Roth S. The effects of isovolumic hemodilution on ocular blood flow. Exp Eye Res. 1992;55:59-63.
17. Neely KA, Ernest JT, Goldstick TK, Linsenmeier RA, Moss J. Isovolemic hemodilution increases retinal tissue oxygen tension. Graefes Arch Clin Exp Ophthalmol. 1996;234:688-694.
18. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol. 1994;118:421-429.
19. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol. 1986;104:34-41.
20. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271-282.
21. Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol. 2000;84:609-613.
22. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108:2249-2257.
23. Hattenbach LO, Steinkamp G, Scharrer I, Ohrloff C. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica. 1998;212:394-398.
24. Paques M, Vallée JN, Herbreteau D, et al. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol. 2000;84:1387-1391.
25. Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina. 1999;19:1-5.
26. Dollery CT, Bulpitt CJ, Kohner EM. Oxygen supply to the retina from the retinal and choroidal circulations at normal and increased arterial oxygen tensions. Invest Ophthalmol Vis Sci. 1969;8:588-594.
27. 2 on relative retinal blood flow in monkeys. Invest Ophthalmol Vis Sci. 1973;12:335-347.
28. 2 prérétinienne. J Fr Ophtalmol. 2003;26:813-818.
29. 2 on the oxygen tension in the vitreous body of the cat. Acta Physiol Scan. 1972;84:261-274.
30. Berkowitz BA. Adult and newborn rat inner retinal oxygenation during carbogen and 100% oxygen breathing. Invest Ophthalmol Vis Sci. 1996;37:2089-2098.
31. 2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res. 1989;49:347-360.
32. Stefansson E, Jensen PK, Eysteinsson T, et al. Optic nerve oxygen tension in pigs and the effect of carbonic anhydrase inhibitors. Invest Ophthalmol Vis Sci. 1999;40:2756-2761.
33. Taki K, Kato H, Endo S, Inada K, Totsuka K. Cascade of acetazolamide-induced vasodilatation. Res Commun Mol Pathol Pharmacol. 1999;103:240-248.
34. Bloodworth JM Jr., Gutgesell HP Jr., Engerman RL. Retinal vasculature of the pig. Light and electron microscope studies. Exp Eye Res. 1965;4:174-178.
35. Rootman J. Vascular system of the optic nerve head and retina in the pig. Br J Ophthalmol. 1971;55:808-819.
36. 2 and bioelectrical activity in excitable tissues. Experientia. 1977;33:1337-1338.
37. Tsacopoulos M, Poitry S, Borselino A. Diffusion and consumption of oxygen in superfused retina of drone (Apis mellifera) in darkness. J Gen Physiol. 1981;77:601-628.
38. Pournaras CJ, Shonat RD, Munoz JL, Petrig BL. New ocular micromanipulator for measurements of retinal and vitreous physiologic parameters in the mammalian eye. Exp Eye Res. 1991;53:723-727.
39. Riva CE, Pournaras CJ, Tsacopoulos M. Regulation of local oxygen tension and blood flow in the inner retina during hyperoxia. J Appl Physiol. 1986;61:592-598.
40. Tsacopoulos M. La physiopathologie de la circulation uvéale. J Fr Ophtalmol. 1979;2:135-142.
41. Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol. 1992;99:177-197.
42. Lowry OH, Roberts RN, Lewis C. The quantitative histochemistry of the retina. J Biol Chem. 1956;220:879-892.
43. Alder VA, Cringle SJ, Constable IJ. The retinal oxygen profile in cats. Invest Ophthalmol Vis Sci. 1983;24:30-36.
44. Yu D-Y, Cringle SJ, Alder V, Su E-N. Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia. Invest Ophthalmol Vis Sci. 1999;40:2082-2087.
45. Riva CE, Grunwald JE, Sinclair SH. Laser Doppler velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci. 1983;24:47-51.
46. th ed. New York: McGraw-Hill; 2001:666-667.
47. 2 and cerebral hemodynamics. Am J Physiol. 1964;206:25-35.
48. Pakola SJ, Grunwald JE. Effects of oxygen and carbon dioxide on human retinal circulation. Invest Ophthalmol Vis Sci. 1993;34:2866-2870.
49. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM. Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology. 1990;97:1321-1328.
50. Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest. 1984;74:1634-1639.
51. th ed. New York/San Francisco: McGraw-Hill/Appleton & Lange; 2001:249-252.
52. Gai X, Taki K, Kato H, Nagaishi H. Regulation of hemoglobin affinity for oxygen by carbonic anhydrase. J Lab Clin Med. 2003;142:414-420.
53. Weiss RG, Marco M. Preservation of canine myocardial high energy phosphates during low-flow ischemia with modification of hemoglobin oxygen. J Clin Invest. 1999;103:739-746.
54. 2 on blood flow, oxygen availability, oxygen consumption rate and ERG in monkeys. Exp Eye Res. 1973;17:391.
55. Findl O, Hansen RM, Fulton AB. The effects of acetazolamide on the electroretinographic responses in rats. Invest Ophthalmol Vis Sci. 1995;36:1019-1026.
56. + extracellulaire au niveau de la couche plexiforme interne de la rétine isolée de la grenouille (Rana ridibunda). Klin Monatsbl Augenheilkd. 1982;180:339-340.
57. 2 dependence of retinal arterial and capillary blood velocity. Acta Ophthalmol Scand. 1995;73:421-424.
58. Hosking SL, Evans DW, Embleton SJ, Houde B, Amos JF, Bartlett JD. Hypercapnia invokes an acute loss of contrast sensitivity in untreated glaucoma patients. Br J Ophthalmol. 2001;85:1352-1356.
59. Sponsel WE, Harrisson J, Elliott WR, Trigo Y, Kavanagh J, Harris A. Dorzolamide hydrochloride and visual function in normal eyes. Am J Ophthalmol. 1997;123:759-766.